Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage-Reference-Cited by-同舟云学术

Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage

Published:2001-08 Issue:2 Volume:100 Page:144-148
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

van der Vliet Hans J.J.,von Blomberg B.Mary E.,Nishi Nobusuke,Reijm Martine,Voskuyl Alexandre E.,van Bodegraven Ad A.,Polman Chris H.,Rustemeyer Thomas,Lips Paul,van den Eertwegh Alfons J.M.,Giaccone Giuseppe,Scheper Rik J.,Pinedo Herbert M.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference26 articles.

1. Analysis of T cell receptor (TCR) expression by human peripheral blood CD4−CD8− α/β T cells demonstrates preferential use of several Vβ genes and an invariant α chain;Porcelli;J. Exp. Med.,1993

2. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1;Chen;J. Immunol.,1997

3. Requirements for CD1d recognition by human invariant Vα24+ CD4−CD8− T cells;Exley;J. Exp. Med.,1997

4. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors;Cui;Science,1997

5. Early quantative and functional deficiency of NK1+ like thymocytes in the NOD mouse;Gombert;Eur. J. Immunol.,1996

Cited by 246 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymic development of human natural killer T cells: recent advances and implications for immunotherapy;Frontiers in Immunology;2024-08-29

2. Deciphering the circulating immunological landscape of thoracic aortic aneurysm: Insights from a two-sample Mendelian randomization study;Heliyon;2024-05

3. Immunology of amyotrophic lateral sclerosis – role of the innate and adaptive immunity;Frontiers in Neuroscience;2023-11-30

4. Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging;Seminars in Immunology;2023-09

5. The emerging paradigm of Unconventional T cells as a novel therapeutic target for celiac disease;International Immunopharmacology;2023-09